Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions

Patent No. EP2791160 (titled "Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions") was filed by Moderna on Dec 14, 2012. The application was issued on Mar 2, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2791160

MODERNA
Application Number
EP12858350A
Filing Date
Dec 14, 2012
Status
Revoked
Apr 18, 2025
Publication Date
Mar 2, 2022